Validation of Unani Pharmacopoeial formulation- Sharbat ZÅ«fÄ Murakkab in patients of SuÄl Ratab (Productive Cough)
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 540
- 试验地点
- 7
- 主要终点
- Improvement in signs and symptoms of SuÄl Ratab (Productive Cough).
研究概览
简要总结
This study is designed as a multicentric open trial in patients with SuÄl Ratab (Productive Cough).After screening, Patients will be enrolled if they satisfy the inclusion and exclusion criteria. The patients will be assessed clinically on follow up. This includes subjective assessment of general well being and physical examination. The total duration of treatment will be 2 weeks . Laboratory parameters for safety assessment will be conducted at baseline and end of study
Composition of SharbatZufa Murakkab:
-Injeer (Ficus carica Linn.) 10 pcs.
2-Tukhm Khatmi (Althaea officinalis Linn.) 10.5 g
3-Aslus Soos (Glycyrrhiza glabraLinn.) 10.5 g
4-Irsa (Iris ensata Thunb.) 10.5 g
5-Zufa Khushk (H. officinalis Linn.) 24 g
6- Maweez Munaqqa (V. vinifera Linn.) 108 g
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of either sex in the age group of 18-65
- •Associated with expectoration.
排除标准
- •Cases of non-productive cough
- •Known cases of respiratory diseases needed concomitant therapy e.g. Pneumonia, Bronchiectasis, Bronchial Asthma, Pulmonary Tuberculosis and Lung Carcinoma.
- •Known cases of Renal/ Hepatic/ Cardiac impairment or the ailments needing long term therapy
- •Pregnant or lactating women.
结局指标
主要结局
Improvement in signs and symptoms of SuÄl Ratab (Productive Cough).
时间窗: 2WEEKS
次要结局
- Haematological and biochemical assessment for safety assessment(2 WEEKS)